Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
This JD.com Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Tickers GILD GTLB JD MHK
Tags Trading Ideas News GILD
From Benzinga
Evaluating Gilead Sciences: Insights From 15 Financial Analysts
Tickers GILD
Tags Benzinga GILD Analyst Ratings
From Benzinga
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
Tickers GILD MRK NEWS
Tags General Top Stories Benzinga
From Benzinga
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
Tickers GILD NEWS
Tags GILD Benzinga Trading Ideas
From Benzinga
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Tickers ALMS FWRG GILD GO
Tags Benzinga ALMS Analyst Ratings
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Tickers AMGN AZN BMRN GILD
Tags GSK AZN Stories That Matter
From Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Tickers AAPL AI BMY GILD
Tags Stories That Matter Expert Ideas GOOG
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers ABBV CSLLY GILD GSK
Tags Benzinga Analyst Ratings Price Target
From Benzinga
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
Tickers GILD
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
Tickers GILD NEWS
Tags Market News BZI/POD Trading Ideas
From Benzinga
Top 4 Health Care Stocks That May Keep You Up At Night
Tickers BFRG DOCS GILD GNFT
Tags Expert Ideas GNFT BFRG
From Benzinga
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
Tickers GILD NEWS
Tags Covid/19 Biotech FDA
From Benzinga
3 Dirt Cheap Stocks to Buy Right Now
Tickers CRSP GILD PFE
Tags CRSP PFE Market News
From Motley Fool
Gilead Sciences Unusual Options Activity For September 20
Tickers GILD
Tags Markets Options Market News
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Tickers CVS GILD NEWS PFE
Tags GILD PFE Wall Street's Most Accurate Analysts
From Benzinga
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Tickers BMY GILD
Tags Market News BMY Recent Press Releases
From Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Tickers GILD NEWS
Tags GILD Benzinga Trading Ideas
From Benzinga
Why Gilead Sciences Stock Thrashed the Market Today
Tickers GILD
Tags Recent Press Releases GILD Market News
From Motley Fool
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
Tickers GILD NEWS
Tags Benzinga Top Stories why it's moving
From Benzinga
What the Options Market Tells Us About Gilead Sciences
Tickers GILD
Tags Options Markets Market News
From Benzinga
Peering Into Gilead Sciences's Recent Short Interest
Tickers GILD
Tags BZI/SHORTHIST Market News Trading Ideas
From Benzinga
Unveiling 10 Analyst Insights On Gilead Sciences
Tickers GILD
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street
Tickers GILD MRK
Tags GILD Health Care Trading Ideas
From Benzinga
Gilead Sciences Options Trading: A Deep Dive into Market Sentiment
Tickers GILD
Tags GILD Benzinga BZI/UOA
From Benzinga
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Tickers GILD
Tags Options Markets Market News
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Tickers GILD NEWS
Tags BZI/POD Market News GILD
From Benzinga
Peering Into Gilead Sciences's Recent Short Interest
Tickers GILD
Tags Market News BZI/SHORTHIST Trading Ideas
From Benzinga
Gilead's Ongoing Battle Against Counterfeit HIV Medications Persists With New Lawsuit, Seizes $750K In Fake Drugs
Tickers GILD NEWS
Tags News General Large Cap
From Benzinga
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
Tickers GILD NEWS
Tags Biotech FDA Stories That Matter
From Benzinga
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
Tickers GILD
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.